| Coronary Artery Disease |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Current Use of Beta Blockers in Patients With Reactive Airway Disease Who Are Hospitalized With Acute Coronary Syndromes
21 November 2008
Beta blockers have a proven benefit in the management of patients with acute coronary syndromes (ACS) and for secondary prevention of coronary events. Current guidelines list such reactive airway dise...
|
Benjamin A. Olenchock,
Gregg G. Fonarow,
Wenqin Pan,
Adrian Hernandez,
Christopher P. Cannon,
Get With The GuidelinesSM Steering Committee
et al.
|
Full-length article
|
pages 295-300
|
|
|
Differentiating ST Elevation Myocardial Infarction and Nonischemic Causes of ST Elevation by Analyzing the Presenting Electrocardiogram
21 November 2008
Guidelines recommend that patients with suggestive symptoms of myocardial ischemia and ST-segment elevation (STE) in ≥2 adjacent electrocardiographic leads should receive immediate reperfusion therapy...
|
Jason B. Jayroe,
David H. Spodick,
Kjell Nikus,
John Madias,
Miguel Fiol,
Antoni Bayés De Luna,
Diego Goldwasser,
Peter Clemmensen,
Yuling Fu,
Anton P. Gorgels,
Samuel Sclarovsky,
Paul D. Kligfield,
Galen S. Wagner,
Charles Maynard,
Yochai Birnbaum
et al.
|
Full-length article
|
pages 301-306
|
|
|
Relation of Death Within 90 Days of Non-ST-Elevation Acute Coronary Syndromes to Variability in Electrocardiographic Morphology
21 November 2008
Electrocardiographic measures can facilitate the identification of patients at risk of death after acute coronary syndromes. This study evaluates a new risk metric, morphologic variability (MV), which...
|
Zeeshan Syed,
Benjamin M. Scirica,
Satishkumar Mohanavelu,
Phil Sung,
Eric L. Michelson,
Christopher P. Cannon,
Peter H. Stone,
Collin M. Stultz,
John V. Guttag
et al.
|
Full-length article
|
pages 307-311
|
|
|
Frequency of Electrocardiographic Recordings in Patients Presenting With Angina Pectoris (from the Investigation of National Coronary Disease Identification)
13 November 2008
The appropriate progression of diagnostic testing for acute angina has been the topic of several recommendations by the American College of Cardiology and American Heart Association (ACC/AHA). We meas...
|
James Li,
Nancy L. Reaven,
Susan E. Funk,
Joseph E. Lovett,
Anthony N. DeMaria
et al.
|
Full-length article
|
pages 312-315
|
|
|
Comparison of Outcomes and Safety of “Facilitated” Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
17 November 2008
Recent studies have documented that use of “facilitated” percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) may be harmful. In-hospital outcom...
|
Raymond G. McKay,
Marcin R. Dada,
Jeffrey F. Mather,
Roger R. Mennet,
Deborah J. Murphy,
Krista W. Maloney,
Jeffrey A. Hirst,
Francis J. Kiernan
et al.
|
Full-length article
|
pages 316-321
|
|
|
Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction
17 November 2008
Although high white blood cell (WBC) count and plasma glucose (PG) and low glomerular filtration rate (GFR) on admission have been associated with poor outcomes after acute myocardial infarction (AMI)...
|
Masami Kosuge,
Kazuo Kimura,
Satoshi Morita,
Sunao Kojima,
Tomohiro Sakamoto,
Masaharu Ishihara,
Yujiro Asada,
Chuwa Tei,
Shunichi Miyazaki,
Masahiro Sonoda,
Kazufumi Tsuchihashi,
Masakazu Yamagishi,
Mutsunori Shirai,
Hisatoyo Hiraoka,
Takashi Honda,
Yasuhiro Ogata,
Hisao Ogawa,
Japanese Acute Coronary Syndrome Study (JACSS) Investigators
et al.
|
Full-length article
|
pages 322-327
|
|
|
Hematologic Parameters, Atherosclerotic Progression, and Prognosis in Patients With Previous Coronary Artery Bypass Grafting (from the Post CABG Trial)
21 November 2008
Although inflammatory markers and anemia have both been associated with prognosis in patients with cardiovascular disease, their relation with atherosclerotic progression in patients with previous cor...
|
Kenneth J. Mukamal,
Gregory A. Wellenius,
Murray A. Mittleman
|
Full-length article
|
pages 328-332
|
|
|
Association of Leukocyte and Neutrophil Counts With Infarct Size, Left Ventricular Function and Outcomes After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
17 November 2008
Elevated leukocyte count during ST-segment elevation myocardial infarction is associated with adverse clinical outcomes. Whether increased leukocyte count after primary percutaneous coronary intervent...
|
Stanley Chia,
John T. Nagurney,
David F.M. Brown,
O. Christopher Raffel,
Fabian Bamberg,
Fred Senatore,
Frans J. Th. Wackers,
Ik-Kyung Jang
et al.
|
Full-length article
|
pages 333-337
|
|
|
Cost-Effectiveness of Drug-Eluting Stents Including the Economic Impact of Late Stent Thrombosis
17 November 2008
Recent studies examining the effectiveness of drug-eluting stents (DES) have found that the use of DES is associated with a significant increase in the incidence of late stent thrombosis (LST). Previo...
|
Kristian B. Filion,
Arup Michael Roy,
Tara Baboushkin,
Stéphane Rinfret,
Mark J. Eisenberg
et al.
|
Full-length article
|
pages 338-344
|
|
|
Comparison of the Sirolimus-Eluting Versus Paclitaxel-Eluting Coronary Stent in Patients With Diabetes Mellitus: The Diabetes and Drug-Eluting Stent (DiabeDES) Randomized Angiography Trial†
13 November 2008
The aim of the present study was to evaluate angiographic late luminal loss after the implantation of sirolimus-eluting Cypher stents and paclitaxel-eluting Taxus stents in patients with diabetes. The...
|
Michael Maeng,
Lisette Okkels Jensen,
Anders Michael Galloe,
Per Thayssen,
Evald Hoej Christiansen,
Knud Nørregaard Hansen,
Steffen Helqvist,
Hans Erik Botker,
Jens Flensted Lassen,
Leif Thuesen
et al.
|
Full-length article
|
pages 345-349
|
|
|
Relation of High-Density Lipoprotein Cholesterol to Mortality After Percutaneous Coronary Interventions in Patients With Low-Density Lipoprotein <70 mg/dl
21 November 2008
High-density lipoprotein (HDL) cholesterol level is a strong predictor of morbidity and mortality in the general population. Conflicting data exist on the protective effects of high HDL cholesterol in...
|
Annapoorna S. Kini,
Paul Muntner,
Pedro R. Moreno,
Devin Mann,
Prakash Krishnan,
Michael C. Kim,
Oana C. Rafael,
Michael E. Farkouh,
Samin K. Sharma
et al.
|
Full-length article
|
pages 350-354
|
|
|
Impact of Left Ventricular Dysfunction on Hospital Mortality Among Patients Undergoing Elective Percutaneous Coronary Intervention
17 November 2008
Many patients with systolic dysfunction undergo elective percutaneous coronary intervention (PCI) despite the unknown risk and limited data supporting its use. Therefore, the aim of this study was to ...
|
Thomas W. Wallace,
Jeffrey S. Berger,
Andrew Wang,
Eric J. Velazquez,
David L. Brown
et al.
|
Full-length article
|
pages 355-360
|
| Preventive Cardiology |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Alcohol Drinking and Cardiovascular Risk in a Population With High Mean Alcohol Consumption
17 November 2008
Moderate alcohol consumption has been associated with lower coronary artery disease (CAD) risk. However, data on the CAD risk associated with high alcohol consumption are conflicting. The aim of this ...
|
Maryline Foerster,
Pedro Marques-Vidal,
Gerhard Gmel,
Jean-Bernard Daeppen,
Jacques Cornuz,
Daniel Hayoz,
Alain Pécoud,
Vincent Mooser,
Gérard Waeber,
Peter Vollenweider,
Fred Paccaud,
Nicolas Rodondi
et al.
|
Full-length article
|
pages 361-368
|
|
|
Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy
03 November 2008
Inflammation is associated with coronary artery disease (CAD), and statins reduce the inflammatory marker C-reactive protein (CRP). The effects of ezetimibe, alone or in combination with statins, on C...
|
Thomas A. Pearson,
Christie M. Ballantyne,
Enrico Veltri,
Arvind Shah,
Steven Bird,
Jianxin Lin,
Elizabeth Rosenberg,
Andrew M. Tershakovec
et al.
|
Full-length article
|
pages 369-374
|
|
|
Usefulness of Genetic Polymorphisms and Conventional Risk Factors to Predict Coronary Heart Disease in Patients With Familial Hypercholesterolemia
25 November 2008
Familial hypercholesterolemia (FH) is an autosomal dominant disorder with an associated high risk of coronary heart disease (CHD). The considerable variation in age of onset of CHD in patients with FH...
|
Jeroen B. van der Net,
A. Cecile J.W. Janssens,
Joep C. Defesche,
John J.P. Kastelein,
Eric J.G. Sijbrands,
Ewout W. Steyerberg
et al.
|
Full-length article
|
pages 375-380
|
|
|
Ten-Year All-Cause Mortality in Presumably Healthy Subjects on Lipid-Lowering Drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort)
25 November 2008
Lipid-lowering drugs are one of the most prescribed drugs worldwide. The aim was to compare 10-year all-cause mortality according to initial dyslipidemia status and lipid-lowering drug exposure. The P...
|
Virginie Gardette,
Vanina Bongard,
Jean Dallongeville,
Dominique Arveiler,
Annie Bingham,
Jean-Bernard Ruidavets,
Philippe Amouyel,
Bernadette Haas,
Pierre Ducimetière,
Jean Ferrières
et al.
|
Full-length article
|
pages 381-386
|
|
|
Effect of Combination Nicotinic Acid and Gemfibrozil Treatment on Intermediate Density Lipoprotein, and Subclasses of Low Density Lipoprotein and High Density Lipoprotein in Patients With Combined Hyperlipidemia
28 November 2008
The goal of this study was to determine, using analytic ultracentrifugation, the effect of nicotinic acid alone or nicotinic acid added to gemfibrozil on lipoprotein subclass distribution, including i...
|
H. Robert Superko,
Brenda C. Garrett,
Spencer B. King,
Kathryn M. Momary,
Nicolas A. Chronos,
Peter D. Wood
et al.
|
Full-length article
|
pages 387-392
|
|
|
Once-a-Week Rosuvastatin (2.5 to 20 mg) in Patients With a Previous Statin Intolerance
21 November 2008
The purpose of this study was to determine the efficacy of rosuvastatin dosed once a week in patients with a previous statin adverse event. Rosuvastatin once a week was tolerated by 37 (74%) of the 50...
|
Janelle F. Ruisinger,
James M. Backes,
Cheryl A. Gibson,
Patrick M. Moriarty
|
Full-length article
|
pages 393-394
|
| Arrhythmias and Conduction Disturbances |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Left Atrial Function After Ablation for Paroxysmal Atrial Fibrillation
25 November 2008
Radiofrequency ablation of the pulmonary veins has been used to treat patients with paroxysmal atrial fibrillation (AF), and atrial damage after ablation is an issue of concern. To evaluate left atria...
|
Ana Clara Tude Rodrigues,
Mauricio I. Scannavacca,
Márcia Azevedo Caldas,
Viviane Tiemi Hotta,
Cristiano Pisani,
Eduardo A. Sosa,
Wilson Mathias
et al.
|
Full-length article
|
pages 395-398
|
| Heart Failure |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Usefulness of Type D Personality and Kidney Dysfunction as Predictors of Interpatient Variability in Inflammatory Activation in Chronic Heart Failure
25 November 2008
Tumor necrosis factor-α (TNF-α), soluble TNF-α receptors 1 and 2 (sTNFR1/2), and interleukin (IL)-6 are powerful predictors of mortality in chronic heart failure (CHF). Little is known, however, about...
|
Johan Denollet,
Angélique A. Schiffer,
Martijn Kwaijtaal,
Herbert Hooijkaas,
Eric H. Hendriks,
Jos W. Widdershoven,
Nina Kupper
et al.
|
Full-length article
|
pages 399-404
|
|
|
Relation of Serum Sodium Level to Long-Term Outcome After a First Hospitalization for Heart Failure With Preserved Ejection Fraction
21 November 2008
Hyponatremia is a predictor of adverse short-term outcomes in patients with acute heart failure (HF). The impact of hyponatremia on long-term survival in patients with HF with preserved ejection fract...
|
Dan Rusinaru,
Otilia Buiciuc,
Laurent Leborgne,
Michel Slama,
Ziad Massy,
Christophe Tribouilloy
et al.
|
Full-length article
|
pages 405-410
|
| Cardiomyopathy |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Differentiation of Hypertrophic Cardiomyopathy and Cardiac Amyloidosis from Other Causes of Ventricular Wall Thickening by Two-Dimensional Strain Imaging Echocardiography
28 November 2008
Hypertension is the most common cause of left ventricular (LV) hypertrophy. However, multiple causes can lead to LV hypertrophy, each of which has different histological and mechanical properties. To ...
|
Jing Ping Sun,
William J. Stewart,
Xing Sheng Yang,
Robert O. Donnell,
Angel R. Leon,
Joel M. Felner,
James D. Thomas,
John D. Merlino
et al.
|
Full-length article
|
pages 411-415
|
| Congenital Heart Disease |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Prenatal Diagnosis and Outcome of Isolated Vascular Rings
28 November 2008
The purpose of this study was to describe our experience in the ultrasound visualization and management of prenatally diagnosed isolated vascular rings. From January 2002 to December 2007, a total of ...
|
Giulia Tuo,
Paolo Volpe,
Gian Lauro Bava,
Sara Bondanza,
Valentina De Robertis,
Giacomo Pongiglione,
Maurizio Marasini
et al.
|
Full-length article
|
pages 416-419
|
|
|
Adverse Left Ventricular Mechanics in Adults With Repaired Tetralogy of Fallot
28 November 2008
Left ventricular (LV) dysfunction is a predictor of adverse outcomes in patients with repaired tetralogy of Fallot (TOF). However, the mechanisms for LV dysfunction are not well understood. The aim of...
|
Nikolaos Tzemos,
Louise Harris,
Shemy Carasso,
Laura Dos Subira,
Matthias Greutmann,
Yves Provost,
Andrew N. Redington,
Harry Rakowski,
Samuel C. Siu,
Candice K. Silversides
et al.
|
Full-length article
|
pages 420-425
|
| Editorials |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Adverse Consequences of the 50% Misconception
28 November 2008
It is often claimed that only 50% of the incidence of coronary artery disease in the population can be attributed to the standard major risk factors. A careful review of published research demonstrate...
|
William B. Kannel,
Ramachandran S. Vasan
|
Discussion
|
pages 426-427
|
|
|
Memorable Cardiology Quotes
21 November 2008
For >3 decades, my career has focused on preventive health issues and evidence-based medicine, with specific reference to the primary and secondary prevention of coronary artery disease. I've been ...
|
Barry A. Franklin
|
Discussion
|
pages 428-430
|
| From the Editor |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Fifty Years of Hypertrophic Cardiomyopathy†
In 1869, Liouville and Hallopeau each reported a patient who probably had hypertrophic cardiomyopathy (HC). The 2 investigators noted striking hypertrophy of the ventricular septum, and each considere...
|
William Clifford Roberts
|
Editorial
|
pages 431-434
|
| Readers' Comments |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Relation of Body Mass Index to Five-Year Survival in Patients With ST-Elevation Myocardial Infarction
In a recent paper/study, Lee et al reported that body mass index (BMI) was positively correlated with 180-day survival in a group of 3,734 patients from the Korean Acute Myocardial Infarction Registry...
|
Anna Kozieradzka,
K.A. Kaminski,
S. Dobrzycki,
W.J. Musial
|
Correspondence
|
page 435
|
|
|
Erratum
Erratum for Barter and Ginsberg, “Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia” Am J Cardiol 2008;102:1040–1045.
|
|
Erratum
|
page 435
|
| Frontmatter |
| |
Article Title |
Author(s) |
Type |
Pages |
|
|
Editorial Board
|
|
Editorial board
|
page A2
|
|
|
Contents
|
|
Contents list
|
page A4
|
